OR WAIT 15 SECS
© 2020 MJH Life Sciences and BioPharm International. All rights reserved.
© 2020 MJH Life Sciences™ and BioPharm International. All rights reserved.
March 28, 2020
AzarGen’s biosimilar, made in iBio’s plant-based system, will be compared to the original molecule in pre-clinical studies.
September 03, 2019
The partnership will provide cost effective biologics for the world market.
A global agreement with Polpharma Biologics gives Sandoz commercialization rights to a proposed biosimilar natalizumab for relapsing-remitting multiple sclerosis.
June 15, 2019
This article provides a review of various 2000-L single-use bioreactors used by biopharmaceutical suppliers for commercial production.
April 03, 2019
Pharmaceutical Technology and BioPharm International will present a Keynote Session on Meeting Bioprocessing Manufacturing Capacity Demands on Wednesday, April 3, 2019, during INTERPHEX 2019 at the Javits Center in New York City.
April 01, 2019
To achieve further cost reductions in biosimilar manufacturing, a move away from traditional models is necessary.
January 14, 2019
The company is set to expand biologics and fill/finish capacity at its biologics manufacturing sites in Madison, WI, and Bloomington, IN.
January 01, 2019
Kinetic models can be used to study aggregation and fragmentation to help ensure stability.
November 14, 2018
Experts believe that the contract development and manufacturing organization market will reach $17.38 billion by 2022, with disruptive business models using Industrial Internet of Things (IIot) and single-use technologies proving more profitable and efficient in the long term.
October 01, 2018
The maturation of single-use technologies presents commercial bioprocessing options for small-volume drug products.